scholarly journals Ebola Virus Ribonucleic Acid Detection in Semen More Than Two Years After Resolution of Acute Ebola Virus Infection

2017 ◽  
Vol 4 (3) ◽  
Author(s):  
William A Fischer ◽  
Jerry Brown ◽  
David Alain Wohl ◽  
Amy James Loftis ◽  
Sam Tozay ◽  
...  
Keyword(s):  
Virus Infection ◽  
Ribonucleic Acid ◽  
Ebola Virus ◽  
Infectious Virus ◽  
Virus Disease ◽  
Viral Rna ◽  
Ebola Virus Disease ◽  
Positive Specimen ◽  
Ebola Virus Infection

Abstract Among 149 men who survived Ebola virus disease (EVD) and donated semen 260–1016 days after EVD onset, Ebola virus (EBOV) ribonucleic acid (RNA) was detected in 13 (9%). Of 137 men who donated semen 2 years after EVD onset, 11 (8%) had an EBOV RNA-positive specimen. The mechanism underlying the persistence of EBOV RNA in semen is unclear, and it is unclear whether the detection of viral RNA represents the presence of infectious virus.

scholarly journals Seroprevalence of Ebola virus infection in Bombali District, Sierra Leone

2017 ◽  
Author(s):  
Nadege Goumkwa Mafopa ◽  
Gianluca Russo ◽  
Raoul Emeric Guetiya Wadoum ◽  
Emmanuel Iwerima ◽  
Vincent Batwala ◽  
...  
Keyword(s):  
Immune Response ◽  
Virus Infection ◽  
West Africa ◽  
Sierra Leone ◽  
Ebola Virus ◽  
Virus Disease ◽  
Asymptomatic Infection ◽  
Ebola Virus Disease ◽  
Efficient Immune Response ◽  
Ebola Virus Infection

A serosurvey of anti-Ebola Zaire virus nucleoprotein IgG prevalence was carried out among Ebola virus disease survivors and their Community Contacts in Bombali District, Sierra Leone. Our data suggest that the specie of Ebola virus (Zaire) responsible of the 2013-2016 epidemic in West Africa may cause mild or asymptomatic infection in a proportion of cases, possibly due to an efficient immune response.

scholarly journals Biosafety level-2 laboratory diagnosis of Zaire Ebola virus disease imported from Liberia to Nigeria

2016 ◽  
Vol 5 (1) ◽  
Author(s):  
Olumuyiwa B. Salu ◽  
Ayorinde B. James ◽  
Bamidele O. Oke ◽  
Mercy R. Orenolu ◽  
Roosevelt A. Anyanwu ◽  
...  
Keyword(s):  
Ebola Virus ◽  
Virus Disease ◽  
Rna Extraction ◽  
Molecular Techniques ◽  
Viral Rna ◽  
Sub Saharan Africa ◽  
Ebola Virus Disease ◽  
Rt Pcr ◽  
Route Of Transmission ◽  
Biosafety Level

Introduction: Global travel is an efficient route of transmission for highly infectious pathogens and increases the chances of such pathogens moving from high disease-endemic areas to new regions. We describe the rapid and safe identification of the first imported case of Ebola virus disease in a traveler to Lagos, Nigeria, using conventional reverse transcription polymerase chain reaction (RT-PCR) in a biosafety level (BSL)-2 facility.Case presentation: On 20 July 2014, a traveler arrived from Liberia at Lagos International Airport and was admitted to a private hospital in Lagos, with clinical suspicion of Ebola virus disease.Methodology and Outcome: Blood and urine specimens were collected, transported to the Virology Unit Laboratory at the College of Medicine, University of Lagos, and processed under stringent biosafety conditions for viral RNA extraction. RT-PCR was set-up to query the Ebola, Lassa and Dengue fever viruses. Amplicons for pan-filoviruses were detected as 300 bp bands on a 1.5% agarose gel image; there were no detectable bands for Lassa and Dengue viral RNA. Nucleotide BLAST and phylogenetic analysis of sequence data of the RNA-dependent RNA polymerase (L) gene confirmed the sequence to be Zaire ebolavirus (EBOV/Hsap/ NGA/2014/LIB-NIG 01072014; Genbank: KM251803.1).Conclusion: Our BSL-2 facility in Lagos, Nigeria, was able to safely detect Ebola virus disease using molecular techniques, supporting the reliability of molecular detection of highly infectious viral pathogens under stringent safety guidelines in BSL-2 laboratories. This is a significant lesson for the many under-facilitated laboratories in resource-limited settings, as is predominantly found in sub-Saharan Africa.

scholarly journals A THEORETICAL STUDY ON FRACTIONAL EBOLA HEMORRHAGIC FEVER MODEL

Fractals ◽  
2021 ◽  
Author(s):  
SHAHER MOMANI ◽  
R. P. CHAUHAN ◽  
SUNIL KUMAR ◽  
SAMIR HADID
Keyword(s):  
Virus Infection ◽  
Ebola Virus ◽  
Virus Disease ◽  
Numerical Technique ◽  
Disease Model ◽  
Hemorrhagic Fever ◽  
Health Concern ◽  
Ebola Hemorrhagic Fever ◽  
Conformable Derivatives ◽  
Ebola Virus Infection

The Ebola virus infection (EVI), generally known as Ebola hemorrhagic fever, is a major health concern. The occasional outbreaks of virus occur primarily in certain parts of Africa. Many researches have been devoted to the study of the Ebola virus disease. In this paper, we have taken susceptible-infected-recovered-deceased-environment (SIRDP) system to investigate the dynamics of Ebola virus infection. We adopted fractional operators for a better illustration of model dynamics and memory effects. Initially, the Ebola disease model is modified with Caputo–Fabrizio arbitrary operator in Caputo sense (CFC) and we employed the fixed-point results for the existence and uniqueness of the solution of the fractional system. Further, we adopted the arbitrary fractional conformable and [Formula: see text]-conformable derivatives to the alternative representation of the model. For the numerical approximation of the system, we show a numerical technique based on the fundamental theorem of fractional calculus for CFC derivative and a numerical scheme called the Adams–Moulton for conformable derivatives. Finally, for the validation of theoretical results, the numerical simulations are displayed.

scholarly journals Mapping the zoonotic niche of Ebola virus disease in Africa

eLife ◽  
2014 ◽  
Vol 3 ◽  
Author(s):  
David M Pigott ◽  
Nick Golding ◽  
Adrian Mylne ◽  
Zhi Huang ◽  
Andrew J Henry ◽  
...  
Keyword(s):  
West Africa ◽  
Ebola Virus ◽  
Virus Disease ◽  
Zoonotic Transmission ◽  
Ebola Virus Disease ◽  
Distribution Models ◽  
Location Data ◽  
Population Sizes ◽  
Risk Areas ◽  
Ebola Virus Infection

Ebola virus disease (EVD) is a complex zoonosis that is highly virulent in humans. The largest recorded outbreak of EVD is ongoing in West Africa, outside of its previously reported and predicted niche. We assembled location data on all recorded zoonotic transmission to humans and Ebola virus infection in bats and primates (1976–2014). Using species distribution models, these occurrence data were paired with environmental covariates to predict a zoonotic transmission niche covering 22 countries across Central and West Africa. Vegetation, elevation, temperature, evapotranspiration, and suspected reservoir bat distributions define this relationship. At-risk areas are inhabited by 22 million people; however, the rarity of human outbreaks emphasises the very low probability of transmission to humans. Increasing population sizes and international connectivity by air since the first detection of EVD in 1976 suggest that the dynamics of human-to-human secondary transmission in contemporary outbreaks will be very different to those of the past.

scholarly journals Virtual screen for repurposing approved and experimental drugs for candidate inhibitors of EBOLA virus infection

F1000Research ◽  
2015 ◽  
Vol 4 ◽  
pp. 34 ◽  
Author(s):  
Veljko Veljkovic ◽  
Philippe M. Loiseau ◽  
Bruno Figadere ◽  
Sanja Glisic ◽  
Nevena Veljkovic ◽  
...  
Keyword(s):  
Virtual Screening ◽  
Virus Infection ◽  
Ebola Virus ◽  
Virus Disease ◽  
Virtual Screen ◽  
Experimental Drugs ◽  
Theoretical Criterion ◽  
Approved Drugs ◽  
Molecular Libraries ◽  
Ebola Virus Infection

The ongoing Ebola virus epidemic has presented numerous challenges with respect to control and treatment because there are no approved drugs or vaccines for the Ebola virus disease (EVD). Herein is proposed simple theoretical criterion for fast virtual screening of molecular libraries for candidate inhibitors of Ebola virus infection. We performed a repurposing screen of 6438 drugs from DrugBank using this criterion and selected 267 approved and 382 experimental drugs as candidates for treatment of EVD including 15 anti-malarial drugs and 32 antibiotics. An open source Web server allowing screening of molecular libraries for candidate drugs for treatment of EVD was also established.

scholarly journals Involvement of Surfactant Protein D in Ebola Virus Infection Enhancement via Glycoprotein Interaction

Viruses ◽  
2018 ◽  
Vol 11 (1) ◽  
pp. 15 ◽  
Author(s):  
Anne-Laure Favier ◽  
Olivier Reynard ◽  
Evelyne Gout ◽  
Martin van Eijk ◽  
Henk P. Haagsman ◽  
...  
Keyword(s):  
Virus Infection ◽  
Ebola Virus ◽  
Virus Disease ◽  
Specific Interaction ◽  
Surfactant Protein ◽  
Immune Defense ◽  
Innate Immune ◽  
Surfactant Protein D ◽  
Viral Spread ◽  
Ebola Virus Infection

Since the largest 2014–2016 Ebola virus disease outbreak in West Africa, understanding of Ebola virus infection has improved, notably the involvement of innate immune mediators. Amongst them, collectins are important players in the antiviral innate immune defense. A screening of Ebola glycoprotein (GP)-collectins interactions revealed the specific interaction of human surfactant protein D (hSP-D), a lectin expressed in lung and liver, two compartments where Ebola was found in vivo. Further analyses have demonstrated an involvement of hSP-D in the enhancement of virus infection in several in vitro models. Similar effects were observed for porcine SP-D (pSP-D). In addition, both hSP-D and pSP-D interacted with Reston virus (RESTV) GP and enhanced pseudoviral infection in pulmonary cells. Thus, our study reveals a novel partner of Ebola GP that may participate to enhance viral spread.

scholarly journals Variation around the dominant viral genome sequence contributes to viral load and outcome in patients with Ebola virus disease

2020 ◽  
Vol 21 (1) ◽  
Author(s):  
Xiaofeng Dong ◽  
Jordana Munoz-Basagoiti ◽  
Natasha Y. Rickett ◽  
Georgios Pollakis ◽  
William A. Paxton ◽  
...  
Keyword(s):  
Viral Load ◽  
Genome Sequence ◽  
Protein Function ◽  
Viral Protein ◽  
Viral Genome ◽  
Rna Synthesis ◽  
Ebola Virus ◽  
Virus Disease ◽  
Viral Rna ◽  
Ebola Virus Disease

Abstract Background Viral load is a major contributor to outcome in patients with Ebola virus disease (EVD), with high values leading to a fatal outcome. Evidence from the 2013–2016 Ebola virus (EBOV) outbreak indicated that different genotypes of the virus can have different phenotypes in patients. Additionally, due to the error-prone nature of viral RNA synthesis in an individual patient, the EBOV genome exists around a dominant viral genome sequence. The minor variants within a patient may contribute to the overall phenotype in terms of viral protein function. To investigate the effects of these minor variants, blood samples from patients with acute EVD were deeply sequenced. Results We examine the minor variant frequency between patients with acute EVD who survived infection with those who died. Non-synonymous differences in viral proteins were identified that have implications for viral protein function. The greatest frequency of substitution was identified at three codon sites in the L gene—which encodes the viral RNA-dependent RNA polymerase (RdRp). Recapitulating this in an assay for virus replication, these substitutions result in aberrant viral RNA synthesis and correlate with patient outcome. Conclusions Together, these findings support the notion that in patients who survived EVD, in some cases, the genetic variability of the virus resulted in deleterious mutations that affected viral protein function, leading to reduced viral load. Such mutations may also lead to persistent strains of the virus and be associated with recrudescent infections.

Sign in / Sign up

Export Citation Format

Share Document